The implantable drug delivery devices market is segmented on the lines of its product type, technology, application and regional. Based on product type segmentation it covers implantable drug infusion pumps, implantable brachytherapy seeds, implantable intraocular drug delivery devices, implantable contraceptive drug delivery devices, implantable bio absorbable stents and implantable coronary drug eluting stents. Under technology segmentation the implantable drug delivery devices market contains non biodegradable implantable drug delivery device technology and biodegradable implantable drug delivery device technology. The implantable drug delivery devices market is segmented on the lines of its application like oncology, birth control/ contraception, cardiovascular, ophthalmology and others such as chronic pain causing diseases and diabetes. The implantable drug delivery devices markets geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
Implantable devices having many functions such as it vascular stents preserve flow of blood. The electro-stimulation devices control heart block spurious in the brain. Implantable drug delivery devices permit site specific drug management where that drug requires more. There has been rising union between drug therapies and implantable devices such as devices that carry drugs as prime action.
The implantable drug delivery devices market is expected to exceed more than US$ 34.0 billion by 2024; Growing at a CAGR of more than 8.5% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets for Implantable drug delivery devices market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market, current market trends and situations. Key players profiled in the report include Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Merck, pSivida Corp., Boston Scientific Corporation, Abbott Laboratories and Bausch and Lomb Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
This report provides:
1) An overview of the global market for implantable drug delivery devices and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2015 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for implantable drug delivery devices.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The Implantable drug delivery devices Market has been segmented as below:
The Implantable drug delivery devices Market is Segmented on the lines of Application Analysis, Product Type Analysis, Technology Analysis and Regional Analysis. By Application Analysis this market is segmented on the basis of Oncology, Birth control/ contraception, Cardiovascular, Ophthalmology and Other (chronic pain causing diseases, diabetes). By Product Type Analysis this market is segmented on the basis of Implantable drug infusion pumps, Implantable brachytherapy seeds, Implantable intraocular drug delivery devices, Implantable contraceptive drug delivery devices, Implantable bio absorbable stents and Implantable coronary drug eluting stents.
By Technology Analysis this market is segmented on the basis of Non biodegradable implantable drug delivery device technology and Biodegradable implantable drug delivery device technology. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
The major driving factors of implantable drug delivery devices market are as follows:
Driving factors for the global contraceptive drug delivery implants market
NGO and government initiatives to support contraceptive goods
Increasing frequency of unwanted pregnancies
Driving factors for the global intraocular drug delivery implants market
Increasing patient group for diabetic retinopathy and diabetes
Growing aging population globally
Driving factors for the global implantable drug infusion pumps market
High predominance of chronic pain causing disorders
Increasing frequency of colorectal cancer globally
Driving factors for the global brachytherapy seeds market
Appearance of new disease appliances
Growing prevalence of prostate cancer globally
Driving factors for the global coronary stents
Increasing many interventional cardiologists
Rising frequency of cardiovascular diseases
The restraining factors of implantable drug delivery devices market are as follows:
Strict CE and FDA approval norms.
The introduction of internal product substitutes, lawsuits and product recalls.
Request Sample Report from here: https://www.marketresearchengine.com/reportdetails/implantable-drug-delivery-devices-market
Table of Contents
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Implantable Drug Delivery Devices Market, By Product Types
Chapter 5 Global Implantable Drug Delivery Devices Market, By Technology
Chapter 6 Global Implantable Drug Delivery Devices Market, By Applications
Chapter 7 Implantable Drug Delivery Devices Market By Geography
Chapter 8 Recommendations
Chapter 9 Competitive Landscape
Chapter 10 Company Profiles
10.2 Bausch & Lomb Inc.
10.3 Medtronic Inc.
10.4 Allergan, Inc.
10.5 Psivida Corp.
10.6 Bayer Healthcare
10.8 Boston Scientific Corporation
10.9 Abbott Laboratories
Other Related Market Research Reports:
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States